The DOI matches its Crossref record; 327 of the 327 references it cites were found in a registry or an index.
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
Open accessAbstract
This comprehensive, pedagogically-oriented review is aimed at a heterogeneous audience representative of the allied disciplines involved in research and patient care. After a foreword on epidemiology, genetics, and risk factors, the amyloid cascade model is introduced and the main neuropathological hallmarks are discussed. The progression of memory, language, visual processing, executive, attentional, and praxis deficits, and of behavioral symptoms is presented. After a summary on neuropsychological assessment, emerging biomarkers from cerebrospinal fluid assays, magnetic resonance imaging, nuclear medicine, and electrophysiology are discussed. Existing treatments are briefly reviewed, followed by an introduction to emerging disease-modifying therapies such as secretase modulators, inhibitors of Abeta aggregation, immunotherapy, inhibitors of tau protein phosphorylation, and delivery of nerve growth factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · cited 1×
“Patients with AD are more likely to carry the e4 allele than the general population, and a proportional relationship between gene dose and risk and age of onset has been found.(11) Conversely, the e2 allele may confer a relative protection.”
BackgroundMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · cited 1×
“In addition, functional status is assessed using tools such as the Activities of Daily Living (ADL) scale, and the presence, severity and impact of neuropsychiatric symptoms and associated caregiver distress can be evaluated using the Neuropsychiatric Inventory (NPI).(141,142) Traditional depression scales such as the…”
MethodGlobal prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
The Global Deterioration Scale for assessment of primary degenerative dementia
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 4,986
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Furthermore, in recent years evidence has accumulated pointing to a significant neurotoxicity of Abeta oligomers, which have much larger surface-to-volume ratio and diffusivity.(37) Neurofibrillary tangles, the other neuropathological hallmark of AD, are principally composed of abnormally phosphorylated tau protein, a…”
BackgroundOverdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“Some studies have found a correlation between plaque counts and the clinical severity of dementia, but according to others, plaque density alone does not account for the degree of cognitive impairment.(41,49) The accumulation of neurofibrillary pathology follows a hierarchical pattern, in which alterations are initial…”
BackgroundGauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Greicius, M. D., Srivastava, G., Reiss, A. L., & Menon, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308627101 · Cited by 3,684 · cited 1×
“It also reveals dysfunctional default-mode functional connectivity during resting state.(178,195) Structural as well as functional MRI can provide potentially useful biomarkers and recent proposals for revised diagnostic criteria include them alongside clinical assessment, however at present their viability is somewha…”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“Conversely, the e2 allele may confer a relative protection.(12) There is also some evidence indicating that variants of the gene encoding for the insulindegrading enzyme (IDE), which is active in the degradation of amyloid-b (Abeta), may predispose individuals to the disease.”
BackgroundCholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
Damasio, A. R. (1989) · Cognition · doi:10.1016/0010-0277(89)90005-x · Cited by 1,538 · cited 1×
“This temporal gradient reflects the fact that, while the entorhinal cortex and the hippocampus are essential for the acquisition and consolidation of new memories, long-term memories are consolidated into a diffuse multifocal neocortical representation.(62,63) Interestingly, in semantic dementia, early degeneration of…”
BackgroundUber eine eigenartige Erkrankung der Hirnrinde
Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“Several studies converge in indicating that a history of depression can predispose to the disease; of note, even though depression may also represent a prodromal manifestation of AD, the risk of developing AD has been reported to be higher in individuals who develop depressive symptoms early in life, supporting the hy…”
BackgroundRetrograde amnesia and memory consolidation: a neurobiological perspective
Squire, L. R., & Alvarez, P. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80023-9 · Cited by 1,416
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
EEG dynamics in patients with Alzheimer's disease
Jeong, J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.01.001 · Cited by 1,337
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000159740.16984.3c · Cited by 1,329
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · cited 1×
“As confirmed by clinico-pathological studies, the cognitive deficits observed in AD mainly follow synaptic loss and axonal dysfunction, occurring initially in the entorhinal cortex and hippocampus and subsequently in associative neocortical regions.(41,52) The consequences of diffuse pathology are exacerbated by the l…”
BackgroundDonepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
Attention and executive deficits in Alzheimer's disease: A critical review
Perry, R. J. (1999) · Brain · doi:10.1093/brain/122.3.383 · Cited by 1,180
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041616 · Cited by 1,159
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Towards a Theory of Dementia Care: Personhood and Well-being
Kitwood, T., & Bredin, K. (1992) · Ageing and Society · doi:10.1017/s0144686x0000502x · Cited by 1,129 · cited 1×
“In addition, person-centered therapeutic interventions that contribute to improving the social psychology milieu can reveal the emotional underpinnings of many behaviors associated with AD, enabling the evaluation of potential coping strategies and alleviating caregiver and patient distress.(275,276)”
BackgroundThe spectrum of behavioral changes in Alzheimer's disease
Mega, M. S., Cummings, J. L., Fiorello, T., & Gornbein, J. (1996) · Neurology · doi:10.1212/wnl.46.1.130 · Cited by 1,115
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., U, H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., et al. (2005) · Nature Medicine · doi:10.1038/nm1239 · Cited by 1,050
Review Article: Genetics of Alzheimer Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987
Rosler, M., Anand, R., Cicin-Sain, A., Gauthier, S., Agid, Y., Dal-Bianco, P., Stahelin, H. B., Hartman, R., Gharabawi, M., & Bayer, T. (1999) · BMJ · doi:10.1136/bmj.318.7184.633 · Cited by 943
Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia
Yaffe, K., Sawaya, G., Lieberburg, I., & Grady, D. (1998) · JAMA · doi:10.1001/jama.279.9.688 · Cited by 941
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910
Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 898
Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., Butterworth, M., & Orrell, M. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.3.248 · Cited by 876
Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
Mittelman, M. S. (1996) · JAMA · doi:10.1001/jama.1996.03540210033030 · Cited by 826
Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789
Semantic dementia: a unique clinicopathological syndrome
Hodges, J. R., & Patterson, K. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70266-1 · Cited by 772
Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.-C., et al. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 770
Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Treatment of Alzheimer's disease; current status and new perspectives
scarpini, E., Schelterns, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 721
Parsons, C. G., Stöffler, A., & Danysz, W. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.013 · Cited by 707
Clinical Dementia Rating (CDR)
(2001) · Management of Dementia · doi:10.3109/9780203213896-34 · Cited by 696
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis
LeBlanc, E. S., Janowsky, J., Chan, B. K. S., & Nelson, H. D. (2001) · JAMA · doi:10.1001/jama.285.11.1489 · Cited by 659
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Hodges, J. (1995) · Neuropsychologia · doi:10.1016/0028-3932(94)00127-b · Cited by 646
Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20864 · Cited by 638
The Prevalence and Malignancy of Alzheimer Disease: A Major Killer
Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040001001 · Cited by 619
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?
Chételat, G., Desgranges, B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J.-C. (2003) · Neurology · doi:10.1212/01.wnl.0000055847.17752.e6 · Cited by 602
Pfefferbaum, A., Wenegrat, B. G., Ford, J. M., Roth, W. T., & Kopell, B. S. (1984) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(84)90027-3 · Cited by 573
Bozzali, M. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.742 · Cited by 568
Minoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560
Hippocampal formation glucose metabolism and volume losses in MCI and AD
De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A. D., Hyman, B. T., Crain, B., Tang, M.-X., & Phelps, C. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380804 · Cited by 547 · cited 1×
“Approximately 60% of patients with AD have at least one APOE e4 allele, and a study on 2200 patients indicated that addition of APOE genotyping to clinical diagnosis, while reducing its sensitivity, can improve it specificity from about 55% to more than 80%.(169) At the time of writing, APOE genotyping is not frequent…”
BackgroundRivastigmine for Alzheimer’s disease.
Birks, J. S., Chong, L.-Y., & Grimley Evans, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001191.pub4 · Cited by 534
Wilson, B., Cockburn, J., Baddeley, A., & Hiorns, R. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400940 · Cited by 530
Laird, F. M., Cai, H., Savonenko, A. V., Farah, M. H., He, K., Melnikova, T., Wen, H., Chiang, H.-C., Xu, G., Koliatsos, V. E., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2766-05.2005 · Cited by 521
Prevalence and Malignancy of Alzheimer Disease
Lijtmaer, H., Fuld, P. A., & Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040088017 · Cited by 517
Donepezil for dementia due to Alzheimer's disease
Birks, J., & Harvey, R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190 · Cited by 515
Fossey, J., Ballard, C., Juszczak, E., James, I., Alder, N., Jacoby, R., & Howard, R. (2006) · BMJ · doi:10.1136/bmj.38782.575868.7c · Cited by 512
Mechanism of action of memantine
JOHNSON, J., & KOTERMANSKI, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.007 · Cited by 502
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Vandermeeren, M., Mercken, M., Vanmechelen, E., Six, J., Van de Voorde, A., Martin, J., & Cras, P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09823.x · Cited by 495
Perry, R. J., Watson, P., & Hodges, J. R. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00079-2 · Cited by 494
Intracerebroventricular Infusion of Nerve Growth Factor in Three Patients with Alzheimer’s Disease
Eriksdotter Jönhagen, M., Nordberg, A., Amberla, K., Bäckman, L., Ebendal, T., Meyerson, B., Olson, L., Seiger, Å., Shigeta, M., Theodorsson, E., et al. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017069 · Cited by 472
Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3
Hong, M., Chen, D. C. R., Klein, P. S., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25326 · Cited by 469
National Estimates of the Quantity and Cost of Informal Caregiving for the Elderly with Dementia*
Langa, K. M., Chernew, M. E., Kabeto, M. U., Regula Herzog, A., Beth Ofstedal, M., Willis, R. J., Wallace, R. B., Mucha, L. M., Straus, W. L., & Fendrick, A. M. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.10123.x · Cited by 456
Galasko, D., Chang, L., Motter, R., Clark, C. M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.937 · Cited by 442
Hogervorst, E., Williams, J., Budge, M., Riedel, W., & Jolles, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00410-3 · Cited by 439
Attentional control in Alzheimer's disease
Baddeley, A. D. (2001) · Brain · doi:10.1093/brain/124.8.1492 · Cited by 435
Braak, H., Braak, E., Grundke-Iqbal, I., & Iqbal, K. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90288-0 · Cited by 432 · cited 1×
“Hyperphosphorylated tau protein tends to unbind from the microtubules and to accumulate ectopically in perykaria and dendrites, leading to neuronal degeneration and to the appearance of randomly-oriented neurites dispersed in the neuropil, commonly referred to as ‘‘neuropil threads’’ (Figure 3F).(43,44,46) Abeta depos…”
Background11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 410
Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging
Alsop, D. C., Detre, J. A., & Grossman, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<93::aid-ana15>3.0.co;2-8 · Cited by 409
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
GSK-3 is essential in the pathogenesis of Alzheimer's disease
Takashima, A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s335 · Cited by 396
Executive function deficits in early Alzheimer's disease and their relations with episodic memory
BAUDIC, S., BARBA, G., THIBAUDET, M., SMAGGHE, A., REMY, P., & TRAYKOV, L. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.07.002 · Cited by 391
Dickerson, B. C., & Sperling, R. A. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.11.030 · Cited by 376
Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein.
Jaffe, A. B., Toran-Allerand, C. D., Greengard, P., & Gandy, S. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36796-0 · Cited by 367
Posterior Cortical Atrophy: Clinical Characteristics and Differences Compared to Alzheimer’s Disease
Mendez, M. F., Ghajarania, M., & Perryman, K. M. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000058331 · Cited by 363
Therapeutic approaches to Alzheimer's disease
Klafki, H.-W., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006) · Brain · doi:10.1093/brain/awl280 · Cited by 362
Effects of normal aging and Alzheimer's disease on emotional memory.
Kensinger, E. A., Brierley, B., Medford, N., Growdon, J. H., & Suzanne Corkin, A. (2002) · Emotion · doi:10.1037//1528-3542.2.2.118 · Cited by 350
Samochocki, M., Höffle, A., Fehrenbacher, A., Jostock, R., Ludwig, J., Christner, C., Radina, M., Zerlin, M., Ullmer, C., Pereira, E. F. R., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045773 · Cited by 345
The Evolution of Psychiatric Symptoms in Alzheimer's Disease: A Natural History Study
Jost, B. C., & Grossberg, G. T. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb02942.x · Cited by 343
Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis
Mosconi, L., Tsui, W. H., De Santi, S., Li, J., Rusinek, H., Convit, A., Li, Y., Boppana, M., & de Leon, M. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163856.13524.08 · Cited by 336
A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk
Dreses-Werringloer, U., Lambert, J.-C., Vingtdeux, V., Zhao, H., Vais, H., Siebert, A., Jain, A., Koppel, J., Rovelet-Lecrux, A., Hannequin, D., et al. (2008) · Cell · doi:10.1016/j.cell.2008.05.048 · Cited by 318
In-Vivo Imaging of Alzheimer Disease -Amyloid With [11C]SB-13 PET
Verhoeff, N. P. L. G. (2004) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.12.6.584 · Cited by 317
Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background
Olin, J. T., Katz, I. R., Meyers, B. S., Schneider, L. S., & Lebowitz, B. D. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00004 · Cited by 316
Clare, L., Wilson, B. A., Carter, G., Breen, K., Gosses, A., & Hodges, J. R. (2000) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/1380-3395(200002)22:1;1-8;ft132 · Cited by 316
Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase
Asai, M., Hattori, C., Szabó, B., Sasagawa, N., Maruyama, K., Tanuma, S.-I., & Ishiura, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02999-6 · Cited by 303
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water
Kantarci, K., Jack, C. R., Xu, Y. C., Campeau, N. G., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Kokmen, E., Tangalos, E. G., et al. (2001) · Radiology · doi:10.1148/radiology.219.1.r01ap14101 · Cited by 300
THE NATURE OF THE NAMING DEFICIT IN ALZHEIMER'S AND HUNTINGTON'S DISEASE
HODGES, J. R., SALMON, D. P., & BUTTERS, N. (1991) · Brain · doi:10.1093/brain/114.4.1547 · Cited by 294
Longstreth, W. T., Dulberg, C., Manolio, T. A., Lewis, M. R., Beauchamp, N. J., O’Leary, D., Carr, J., & Furberg, C. D. (2002) · Stroke · doi:10.1161/01.str.0000032241.58727.49 · Cited by 294
Wilcock, G. K., Black, S. E., Hendrix, S. B., Zavitz, K. H., Swabb, E. A., & Laughlin, M. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70090-5 · Cited by 290
Executive function deficits in mild Alzheimer's disease.
Lafleche, G., & Albert, M. S. (1995) · Neuropsychology · doi:10.1037//0894-4105.9.3.313 · Cited by 286
VISUOSPATIAL ATTENTION IN DEMENTIA OF THE ALZHEIMER TYPE
PARASURAMAN, R., GREENWOOD, P. M., HAXBY, J. V., & GRADY, C. L. (1992) · Brain · doi:10.1093/brain/115.3.711 · Cited by 274
Porsteinsson, A., Grossberg, G., Mintzer, J., & Olin, J. (2008) · Current Alzheimer Research · doi:10.2174/156720508783884576 · Cited by 272 · cited 1×
“Although there is controversy over the entity of the advantage, there is good agreement among studies showing that memantine can be safely combined with cholinesterase inhibitors.(252) As for cholinesterase inhibitors, there is currently no evidence that memantine alters the accumulation of Abeta and tau protein patho…”
ResultTagliavini, F., Giaccone, G., Frangione, B., & Bugiani, O. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90080-8 · Cited by 271
Self-citationThe Construct of Minor and Major Depression in Alzheimer’s Disease
Starkstein, S. E., Jorge, R., Mizrahi, R., & Robinson, R. G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2086 · Cited by 271
Evaluation of NeuroPage: a new memory aid
Wilson, B. A., Evans, J. J., Emslie, H., & Malinek, V. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.113 · Cited by 262
β‐Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
Carson, J. A., & Turner, A. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00855.x · Cited by 261
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
Itoh, N., Arai, H., Urakami, K., Ishiguro, K., Ohno, H., Hampel, H., Buerger, K., Wiltfang, J., Otto, M., Kretzschmar, H., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1054 · Cited by 256
SPECT perfusion imaging in the diagnosis of Alzheimer’s disease: A clinical-pathologic study
Jagust, W., Thisted, R., Devous, M. D., Van Heertum, R., Mayberg, H., Jobst, K., Smith, A. D., & Borys, N. (2001) · Neurology · doi:10.1212/wnl.56.7.950 · Cited by 255
DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment
Kantarci, K., Petersen, R. C., Boeve, B. F., Knopman, D. S., Weigand, S. D., O’Brien, P. C., Shiung, M. M., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000153076.46126.e9 · Cited by 251
Active and passive immunotherapy for neurodegenerative disorders
Brody, D. L., & Holtzman, D. M. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125529 · Cited by 250 · cited 3×
“One phase II and two phase I trials of other antibodies are also currently under way.(312)”
BackgroundGeerlings, M. I., den Heijer, T., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2008) · Neurology · doi:10.1212/01.wnl.0000308937.30473.d1 · Cited by 248
A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease.
Monsch, A. U., Bondi, M. W., Butters, N., & Paulsen, J. S. (1994) · Neuropsychology · doi:10.1037//0894-4105.8.1.25 · Cited by 243
Kudo, Y., Okamura, N., Furumoto, S., Tashiro, M., Furukawa, K., Maruyama, M., Itoh, M., Iwata, R., Yanai, K., & Arai, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037556 · Cited by 242
Sjögren, M., Minthon, L., Davidsson, P., Granérus, A. K., Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070079 · Cited by 239
Jelic, V., Shigeta, M., Julin, P., Almkvist, O., Winblad, B., & Wahlund, L.-O. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106897 · Cited by 239
Berry, E., Kapur, N., Williams, L., Hodges, S., Watson, P., Smyth, G., Srinivasan, J., Smith, R., Wilson, B., & Wood, K. (2007) · Neuropsychological Rehabilitation · doi:10.1080/09602010601029780 · Cited by 236
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
Li, G., Larson, E. B., Sonnen, J. A., Shofer, J. B., Petrie, E. C., Schantz, A., Peskind, E. R., Raskind, M. A., Breitner, J. C. S., & Montine, T. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277657.95487.1c · Cited by 236
Ballard, C., Lana, M. M., Theodoulou, M., Douglas, S., McShane, R., Jacoby, R., Kossakowski, K., Yu, L.-M., Juszczak, E., & on behalf of the Investigators DART AD (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050076 · Cited by 233
Executive dysfunction in early Alzheimer's disease.
Binetti, G., Magni, E., Padovani, A., Cappa, S. F., Bianchetti, A., & Trabucchi, M. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.91 · Cited by 230
Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer’s Disease
Gauthier, S., Feldman, H., Hecker, J., Vellas, B., Ames, D., Subbiah, P., Whalen, E., & Emir, B. (2002) · International Psychogeriatrics · doi:10.1017/s104161020200858x · Cited by 229
Bullock, R., Touchon, J., Bergman, H., Gambina, G., He, Y., Rapatz, G., Nagel, J., & Lane, R. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x56565 · Cited by 228
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
Cummings, J. L., Schneider, E., Tariot, P. N., & Graham, S. M. (2006) · Neurology · doi:10.1212/01.wnl.0000223333.42368.f1 · Cited by 223
Memory rehabilitation in Alzheimer's disease: a review of progress
De Vreese, L. P., Neri, M., Fioravanti, M., Belloi, L., & Zanetti, O. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.428 · Cited by 222
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
Matsuda, H. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037218 · Cited by 214
Traumatic brain injury and Alzheimer's disease: a review
Van Den Heuvel, C., Thornton, E., & Vink, R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(06)61021-2 · Cited by 213
Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A., & Långström, B. (1995) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199505000-00006 · Cited by 212
Gauthier, S., Wirth, Y., & Möbius, H. J. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1341 · Cited by 206
Language disorders in dementia of the Alzheimer type
Murdoch, B. E., Chenery, H. J., Wilks, V., & Boyle, R. S. (1987) · Brain and Language · doi:10.1016/0093-934x(87)90064-2 · Cited by 205
Syntactic Preservation in Alzheimer's Disease
Kempler, D., Curtiss, S., & Jackson, C. (1987) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3003.343 · Cited by 204
Schuff, N., Amend, D., Ezekiel, F., Steinman, S. K., Tanabe, J., Norman, D., Jagust, W., Kramer, J. H., Mastrianni, J. A., Fein, G., et al. (1997) · Neurology · doi:10.1212/wnl.49.6.1513 · Cited by 203
A Phase II study targeting amyloid-β with 3APS in mild-to-moderate Alzheimer disease
Aisen, P. S., Saumier, D., Briand, R., Laurin, J., Gervais, F., Tremblay, P., & Garceau, D. (2006) · Neurology · doi:10.1212/01.wnl.0000244346.08950.64 · Cited by 201
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Bienias, J. L., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000288181.00826.63 · Cited by 199
Executive Dysfunction in Alzheimer's Disease
Collette, F., Van der Linden, M., & Salmon, E. (1999) · Cortex · doi:10.1016/s0010-9452(08)70785-8 · Cited by 199
Oligomerization and Toxicity of β-Amyloid-42 Implicated in Alzheimer's Disease
El-Agnaf, O. M. A., Mahil, D. S., Patel, B. P., & Austen, B. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3051 · Cited by 195
Early detection of Alzheimer’s disease using neuroimaging
Mosconi, L., Brys, M., Glodzik-Sobanska, L., De Santi, S., Rusinek, H., & de Leon, M. J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.016 · Cited by 187
Colloby, S. J., Fenwick, J. D., Williams, D. E., Paling, S. M., Lobotesis, K., Ballard, C., McKeith, I., & O'Brien, J. T. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0778-5 · Cited by 185
Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180
Galantamine for Alzheimer's disease
Loy, C., & Schneider, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001747.pub2 · Cited by 178
Tau protein and neurodegeneration
Goedert, M. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.015 · Cited by 177
Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease
Hanyu, H., Sakurai, H., Iwamoto, T., Takasaki, M., Shindo, H., & Abe, K. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00043-4 · Cited by 176
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174 · cited 1×
“Interestingly, the plasma Abeta(42)/ Abeta(40) ratio has been reported to be altered in elderly individuals with depressive symptoms with respect to those without depression, leading to the hypothesis that a distinct subtype of depression, referred to as ‘‘amyloid-depression,’’ could be a prodromal manifestation of AD…”
ResultComas‐Herrera, A., Wittenberg, R., Pickard, L., & Knapp, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1830 · Cited by 173
Discovering the person with Alzheimer's disease: Cognitive, emotional and behavioural aspects
Woods, B. T. (2001) · Aging & Mental Health · doi:10.1080/13607860120044756 · Cited by 173
Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery
Gotti, C., Riganti, L., Vailati, S., & Clementi, F. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775474486 · Cited by 171
Choline Acetyltransferase: Celebrating Its Fiftieth Year
Wu, D., & Hersh, L. B. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62051653.x · Cited by 170
Burns, A. S., O'Brien, J. T., Auriacombe, S., Ballard, C., Broich, K., Bullock, R., Feldman, H., Ford, G., Knapp, M., McCaddon, A., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106068299 · Cited by 167
Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease
Beatty, W. W., Salmon, D. P., Butters, N., Heindel, W. C., & Granholm, E. L. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80048-4 · Cited by 165
Harwood, D. G., Sultzer, D. L., & Wheatley, M. V. (2000) · PubMed · Cited by 162
Assembly, Trafficking and Function of γ-Secretase
Kaether, C., Haass, C., & Steiner, H. (2006) · Neurodegenerative Diseases · doi:10.1159/000095267 · Cited by 162
Expression of APP pathway mRNAs and proteins in Alzheimer’s disease
Matsui, T., Ingelsson, M., Fukumoto, H., Ramasamy, K., Kowa, H., Frosch, M. P., Irizarry, M. C., & Hyman, B. T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.050 · Cited by 162
Rombouts, S. A. R. B. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.665 · Cited by 162
Naming and Knowing in Dementia of Alzheimer's Type
Hodges, J. R., Patterson, K. E., Graham, N. L., & Dawson, K. E. (1996) · Brain and Language · doi:10.1006/brln.1996.0077 · Cited by 161
Rivastigmine for Alzheimer's disease
Birks, J., Grimley Evans, J., Iakovidou, V., & Tsolaki, M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001191 · Cited by 159
Anosognosia in Very Mild Alzheimer’s Disease but Not in Mild Cognitive Impairment
Kalbe, E., Salmon, E., Perani, D., Holthoff, V., Sorbi, S., Elsner, A., Weisenbach, S., Brand, M., Lenz, O., Kessler, J., et al. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084704 · Cited by 158
García-Alloza, M., Hirst, W. D., Chen, C., Lasheras, B., Francis, P. T., & Ramírez, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300330 · Cited by 154
Petracca, G., Chemerinski, E., & STARKSTEIN, S. E. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100761x · Cited by 154
Delaère, P., He, Y., Fayet, G., Duyckaerts, C., & Hauw, J.-J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90096-t · Cited by 149
Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases
Helkala, E., Laulumaa, V., Soininen, H., & Riekkinen, P. J. (1988) · Annals of Neurology · doi:10.1002/ana.410240207 · Cited by 148
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Palmer, G. C. (2001) · Current Drug Targets · doi:10.2174/1389450013348335 · Cited by 145
Therapeutic Potential of γ -Secretase Inhibitors and Modulators
Imbimbo, B. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783334015 · Cited by 143
Weggen, S., Rogers, M. V., & Eriksen, J. L. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.004 · Cited by 137
1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging
Catani, M., Cherubini, A., Howard, R. J., Tarducci, R., Pelliccioli, G., Piccirilli, M., Gobbi, G., Senin, U., & Mecocci, P. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00007 · Cited by 136
Minati, L., Grisoli, M., & Bruzzone, M. G. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706297089 · Cited by 136
Self-citationScreening for dementia of the alzheimer type in the community: The utility of the clock drawing test
Cahn, D. A., Salmon, D. P., Monsch, A. U., Butters, N., Wiederholt, W. C., Corey‐Bloom, J., & Barrett-Connor, E. L. (1996) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/11.6.529 · Cited by 133
Salmon, D. P., Heindel, W. C., & Lange, K. L. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799577126 · Cited by 130
Cognitive deficits in preclinical Alzheimer's disease
Small, B. J., Mobly, J. L., Laukka, E. J., Jones, S., & Bäckman, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.6.x · Cited by 130
Alzhemed: A Potential Treatment for Alzheimers Disease
Aisen, P. S. S., Gauthier, S. G., Vellas, B. J., Briand, R., Saumier, D., Laurin, J., & Garceau, D. (2007) · Current Alzheimer Research · doi:10.2174/156720507781788882 · Cited by 128
Language Impairment in Dementia of the Alzheimer Type: A Hierarchical Decline?
Emery, V. O. B. (2000) · The International Journal of Psychiatry in Medicine · doi:10.2190/x09p-n7au-ucha-vw08 · Cited by 128
Antioxidant Vitamin Supplement Use and Risk of Dementia or Alzheimer's Disease in Older Adults
Gray, S. L., Anderson, M. L., Crane, P. K., Breitner, J. C. S., McCormick, W., Bowen, J. D., Teri, L., & Larson, E. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01531.x · Cited by 127
Patterns of prospective and retrospective memory impairment in preclinical Alzheimer's disease.
Jones, S., Livner, Å., & Bäckman, L. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.2.144 · Cited by 127
Cited by
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Resting-state brain networks: literature review and clinical applications
Rosazza, C., & Minati, L. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0636-y · Cited by 514
Self-citationMulti-Modality Cascaded Convolutional Neural Networks for Alzheimer’s Disease Diagnosis
Initiative, T. A. D. N., Liu, M., Cheng, D., Wang, K., & Wang, Y. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9370-4 · Cited by 400
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 394
Metadata
- Authors
- Minati, L., Edginton, T., Grazia Bruzzone, M., & Giaccone, G.
- Venue
- American Journal of Alzheimer's Disease & Other Dementias®
- Publisher
- SAGE Publications
- Published
- 2009-04
- Volume
- 24
- Issue
- 2
- Pages
- 95-121
- ISSN
- 0888-4897 (ISSN-L)
- 1533-3175
- 1938-2731
- OpenAlex
- W1997858799
- Cited by
- 268
- References
- 327
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.